Evidence map›Paper›PMID 22174419›Full record

ArticleThe Journal of biological chemistry2012

Receptor for activated C kinase 1 (RACK1) inhibits function of transient receptor potential (TRP)-type channel Pkd2L1 through physical interaction.

Jungwoo Yang, Qian Wang, Wang Zheng, Jagdeep Tuli, Qiang Li, Yuliang Wu, Shaimaa Hussein, Xiao-Qing Dai, Shiva Shafiei, Xiao-Gai Li and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. The T-type calcium channelosome.Pflugers Archiv : European journal of physiology · 2024
    Review
  2. Regulation of CaPflugers Archiv : European journal of physiology · 2022
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Jungwoo YangDepartment of Physiology, University of Alberta, 7-29 Medical Sciences Building, Edmonton, Alberta T6G 2H7, Canada.
Qian Wang
Wang Zheng
Jagdeep Tuli
Qiang Li
Yuliang Wu
Shaimaa Hussein
Xiao-Qing Dai
Shiva Shafiei
Xiao-Gai Li
Patrick Y Shen
Jian-Cheng Tu
Xing-Zhen Chen
University of Alberta · CAWuhan University · CN

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Pkd2L1 (also called TRPP3) is a non-selective cation channel permeable to Ca(2+), Na(+), and K(+) and is activated by Ca(2+). It is also part of an acid-triggered off-response cation channel complex. We previously reported roles of the Pkd2L1 C-terminal fragments in its channel function, but the role of the N terminus remains unclear. Using a yeast two-hybrid screening, we found that the Pkd2L1 N terminus interacts with the receptor for activated C kinase 1 (RACK1), a scaffolding/anchoring protein implicated in various cellular functions. This interaction requires the last two Trp-Asp (WD) motifs of RACK1 and fragment Ala(19)-Pro(45) of Pkd2L1. The interaction was confirmed by GST pulldown, blot overlay, and co-immunoprecipitation assays. By (45)Ca tracer uptake and two-microelectrode voltage clamp electrophysiology, we found that in Xenopus oocytes with RACK1 overexpression Pkd2L1 channel activity is abolished or substantially reduced. Combining with oocyte surface biotinylation experiments, we demonstrated that RACK1 inhibits the function of Pkd2L1 channel on the plasma membrane in addition to reducing its total and plasma membrane expression. Overexpressing Pkd2L1 N- or C-terminal fragments as potential blocking peptides for the Pkd2L1-RACK1 interaction, we found that Pkd2L1 N-terminal fragment Met(1)-Pro(45), but not Ile(40)-Ile(97) or C-terminal fragments, abolishes the inhibition of Pkd2L1 channel by overexpressed and oocyte-native RACK1 likely through disrupting the Pkd2L1-RACK1 association. Taken together, our study demonstrated that RACK1 inhibits Pkd2L1 channel function through binding to domain Met(1)-Pro(45) of Pkd2L1. Thus, Pkd2L1 is a novel target channel whose function is regulated by the versatile scaffolding protein RACK1.

Indexed as

AnimalsBinding SitesCalciumCalcium ChannelsGTP-Binding ProteinsHEK293 CellsHumansMutagenesisNeoplasm ProteinsOocytesPatch-Clamp TechniquesProtein Interaction Domains and MotifsProtein Structure, TertiaryReceptors, Cell SurfaceReceptors for Activated C KinaseRNA, MessengerCalciumCalcium ChannelsGTP-Binding ProteinsNeoplasm ProteinsPKD2L1 protein, humanRACK1 protein, humanReceptors, Cell SurfaceReceptors for Activated C KinaseRNA, Messenger

Identifiers

PMID22174419
PMCPMC3307287
OpenAlexW2050304682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.